Gamida Cell Stock Jumps Over 100% On FDA Approval
Gamida Cell Ltd. (NASDAQ:GMDA) is an Israeli-based developmental biotechnology company specializing in discovering and advancing cell therapies to fight blood cancer and other illnesses.
Source: valuewalk.com